Votrient 200mg (Pazopanib)

Product Overview

Votrient 200mg is a prescription drug that contains Pazopanib, an anti-cancer targeted treatment used to treat specific kinds of kidney cancer that are advanced, as well as soft tissue sarcoma. It’s part of a category of medications known as tyrosine-kinase inhibitors (TKIs), which are effective by inhibiting specific enzymes responsible for cancer growth as well as blood vessel growth.

Pazopanib blocks multiple receptors, including the vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), as well as c-Kit. These receptors play a vital role in angiogenesis (the creation of blood vessels). By blocking these receptors, Votrient reduces the amount of blood supply essential for their development and growth as well as for survival.

Generic Name: Pazopanib

Brand Name: Votrient

Strength: 200mg per tablet

Dosage Form: Oral tablet

Drug Class: Tyrosine Kinase Inhibitor (TKI)

Indications

Votrient 200mg is indicated for:

• Advanced Renal Cell Carcinoma (RCC):
  It is used to treat those suffering from advanced kidney cancers, in particular in cases where surgery isn’t an option, or when the other treatments are unsuccessful.
• Advanced Soft Tissue Sarcoma:
  Adults with advanced soft tissue sarcomas who previously received chemotherapy.

How Votrient Works

Votrient is a drug that inhibits multiple tyrosine-kinase enzymes that stimulate pathways in tumor cell proliferation as well as angiogenesis. Particularly, Pazopanib blocks:

• VEGFR-1, VEGFR-2, and VEGFR-3: It prevents the growth of tumors by blocking blood vessel development.
• PDGFR-alpha and PDGFR-beta: It disrupts signaling for the growth of tumors and for survival.
• c-Kit: It is implicated in the proliferation of cells in tumors of various types.

Through targeting these pathways, Votrient assists in reducing the size of tumors as well as slowing the progression of tumors. It also helps increase the quality of life for patients.

Dosage and Administration

• The dose recommended by Votrient is 800 mg orally, once a day, typically taken in the form of four tablets of 200mg.
• Tablets must be taken by mouth, preferably with water. May be consumed in combination with and without meals.
• The consistency of dosing times is vital.
• The dosage adjustments are in accordance with the tolerance levels of the patient and adverse effects.
• Monitoring on a regular basis by your doctor is vital for your treatment.
• Don’t alter the dosage or discontinue medication without consulting your doctor.

Side Effects

Common Side Effects:

• Diarrhea
• Hypertension (high blood pressure)
• Hair color changes (hair may become lighter)
• Nausea and vomiting
• Fatigue
• Headache
• Loss of appetite
• Abdominal pain

Serious Side Effects:

• Liver toxicity (elevated liver enzymes, jaundice)
• Heart problems including heart failure or reduced heart function
• Severe hypertension
• Bleeding or clotting disorders
• Gastrointestinal perforation (rare but life-threatening)
• Proteinuria (protein in urine indicating kidney damage)

The patient should report any symptoms such as yellowing of the eyes/face or chest pains, extreme stomach pain, constant vomiting, or swelling of the extremities to their physician.

Precautions and Warnings

• Liver Function: The liver enzymes must be assessed in the course of treatment because of the risk of liver toxicities.
• Blood Pressure: Keep track of your blood pressure regularly, as hypertension is an extremely common adverse effect.
• Heart Health: Heart diseases should be monitored closely.
• Bleeding Risk: Take care when administering this medicine to patients who have bleeding disorders or who are taking anticoagulants.
• Pregnancy and Breastfeeding: Votrient can affect a newborn baby. Women who have the potential to become pregnant must take advantage of effective contraceptives during treatment and for two weeks following the treatment.
• Drug Interactions: Pazopanib is a drug that interacts with a variety of drugs, including CYP3A4 inhibitors/inducers, as well as anticoagulants. Tell your doctor about all the medications you take.
• Avoid Grapefruit and Grapefruit Juice: This can cause an increase in the levels of Pazopanib in the blood and the chance of adverse effects.

Drug Interactions

• CYP3A4 Inhibitors: (e.g., ketoconazole) may increase the levels of Votrients, increasing the risk of adverse side effects.
• CYP3A4 Inducers: (e.g., rifampicin) can decrease Votrient effectiveness.
• Warfarin: A higher risk of bleeding requires constant observation of INR.
• Other Anticancer Drugs: Interaction potential varies, so consult oncologist.

Be sure to provide your physician with an exhaustive list of medicines and other supplements prior to starting Votrient.

Storage Instructions

• Place tablets of Votrient in a sealed container at room temperature, 20°C to 25°C (68°F to 77°F).
• Place the product in its original container to keep it safe from light and moisture.
• Keep the store out of a child’s reach.
• Do not use after the expiration date on the package.

Why Choose Votrient 200mg?

• Targeted cancer therapy: Specifically designed to inhibit cancer growth processes.
• Convenient oral dosing: It is easy to do at home, without the need for an intravenous injection.
• Clinically proven: Evidenced by research showing the effectiveness of this treatment in the advanced stages of RCC as well as soft tissue Sarcoma.
• Improves quality of life: In controlling the growth of tumors and the associated signs.

Patient Counseling and Support

• Use Votrient precisely as directed; Do not miss any doses.
• It is essential to keep track of regular follow-ups for the monitoring of side effects and responses.
• Notify anyone of new or more severe symptoms as soon as they become apparent.
• Keep a healthy and balanced lifestyle. Beware of alcohol and smoking.
• Use effective contraception during treatment.
• Find support groups or counselors to help you cope with the cancer treatment.

Summary

Votrient 200mg (Pazopanib) is an effective oral tyrosine kinase inhibitor that is used to treat advanced renal cell carcinoma that is advanced as well as soft tissue sarcoma. By blocking key pathways to the growth of tumors and blood supply, it helps to slow down the progression of the disease and enhances patient outcomes. Because of the potential for adverse complications, careful monitoring and medical supervision are essential in the course of treatment. Votrient is a major advancement in targeted cancer therapies, providing patients with a safe treatment with oral medication.

Disclaimer

This content is to be educational and not intended to replace professional medical guidance. Follow your doctor’s guidelines and inform them of any problems promptly.